Annual SGA
$26.06 M
+$5.82 M+28.75%
December 31, 2023
Summary
- As of February 8, 2025, RAPT annual SGA is $26.06 million, with the most recent change of +$5.82 million (+28.75%) on December 31, 2023.
- During the last 3 years, RAPT annual SGA has risen by +$13.29 million (+104.06%).
- RAPT annual SGA is now at all-time high.
Performance
RAPT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.45 M
-$242.00 K-3.62%
September 30, 2024
Summary
- As of February 8, 2025, RAPT quarterly SGA is $6.45 million, with the most recent change of -$242.00 thousand (-3.62%) on September 30, 2024.
- Over the past year, RAPT quarterly SGA has dropped by -$449.00 thousand (-6.51%).
- RAPT quarterly SGA is now -16.66% below its all-time high of $7.74 million, reached on March 31, 2024.
Performance
RAPT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.10 B
-$107.49 M-5.38%
September 30, 2024
Summary
- As of February 8, 2025, RAPT TTM SGA is -$2.10 billion, with the most recent change of -$107.49 million (-5.38%) on September 30, 2024.
- Over the past year, RAPT TTM SGA has dropped by -$2.13 billion (-8658.61%).
- RAPT TTM SGA is now -1668.81% below its all-time high of -$118.95 million.
Performance
RAPT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RAPT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.8% | -6.5% | -8658.6% |
| 3 y3 years | +104.1% | +70.8% | -10000.0% |
| 5 y5 years | +403.1% | +272.1% | -10000.0% |
RAPT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.5% | -16.7% | +43.6% | -104.5% | at low |
| 5 y | 5-year | at high | +198.9% | -16.7% | +145.6% | -264.3% | at low |
| alltime | all time | at high | +601.9% | -16.7% | +510.0% | -1668.8% | at low |
RAPT Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.45 M(-3.6%) | $27.33 M(-1.6%) |
| Jun 2024 | - | $6.69 M(-13.5%) | $27.78 M(-0.1%) |
| Mar 2024 | - | $7.74 M(+19.9%) | $27.81 M(+6.7%) |
| Dec 2023 | $26.06 M(+28.8%) | $6.45 M(-6.4%) | $26.06 M(+6.0%) |
| Sep 2023 | - | $6.90 M(+2.6%) | $24.58 M(+8.0%) |
| Jun 2023 | - | $6.72 M(+12.3%) | $22.77 M(+6.0%) |
| Mar 2023 | - | $5.99 M(+20.3%) | $21.48 M(+6.1%) |
| Dec 2022 | $20.24 M(+26.2%) | $4.98 M(-2.0%) | $20.24 M(+2.5%) |
| Sep 2022 | - | $5.08 M(-6.6%) | $19.75 M(+7.1%) |
| Jun 2022 | - | $5.44 M(+14.5%) | $18.45 M(+10.0%) |
| Mar 2022 | - | $4.75 M(+5.7%) | $16.77 M(+4.6%) |
| Dec 2021 | $16.04 M | $4.49 M(+19.0%) | $16.04 M(+6.7%) |
| Sep 2021 | - | $3.77 M(+0.4%) | $15.03 M(+4.0%) |
| Jun 2021 | - | $3.76 M(-6.3%) | $14.45 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $4.01 M(+15.2%) | $13.49 M(+5.7%) |
| Dec 2020 | $12.77 M(+46.5%) | $3.48 M(+8.9%) | $12.77 M(+7.2%) |
| Sep 2020 | - | $3.20 M(+14.1%) | $11.91 M(+14.0%) |
| Jun 2020 | - | $2.80 M(-14.8%) | $10.45 M(+1.1%) |
| Mar 2020 | - | $3.29 M(+25.3%) | $10.34 M(+18.5%) |
| Dec 2019 | $8.72 M(+68.3%) | $2.63 M(+51.5%) | $8.72 M(+18.1%) |
| Sep 2019 | - | $1.73 M(-35.6%) | $7.39 M(+5.3%) |
| Jun 2019 | - | $2.69 M(+60.8%) | $7.02 M(+21.1%) |
| Mar 2019 | - | $1.67 M(+29.7%) | $5.80 M(+11.9%) |
| Dec 2018 | $5.18 M(+39.5%) | $1.29 M(-5.4%) | $5.18 M(+33.2%) |
| Sep 2018 | - | $1.36 M(-7.1%) | $3.89 M(+54.0%) |
| Jun 2018 | - | $1.47 M(+38.9%) | $2.52 M(+138.9%) |
| Mar 2018 | - | $1.06 M | $1.06 M |
| Dec 2017 | $3.71 M | - | - |
FAQ
- What is RAPT Therapeutics annual SGA?
- What is the all time high annual SGA for RAPT Therapeutics?
- What is RAPT Therapeutics annual SGA year-on-year change?
- What is RAPT Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly SGA year-on-year change?
- What is RAPT Therapeutics TTM SGA?
- What is the all time high TTM SGA for RAPT Therapeutics?
- What is RAPT Therapeutics TTM SGA year-on-year change?
What is RAPT Therapeutics annual SGA?
The current annual SGA of RAPT is $26.06 M
What is the all time high annual SGA for RAPT Therapeutics?
RAPT Therapeutics all-time high annual SGA is $26.06 M
What is RAPT Therapeutics annual SGA year-on-year change?
Over the past year, RAPT annual SGA has changed by +$5.82 M (+28.75%)
What is RAPT Therapeutics quarterly SGA?
The current quarterly SGA of RAPT is $6.45 M
What is the all time high quarterly SGA for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly SGA is $7.74 M
What is RAPT Therapeutics quarterly SGA year-on-year change?
Over the past year, RAPT quarterly SGA has changed by -$449.00 K (-6.51%)
What is RAPT Therapeutics TTM SGA?
The current TTM SGA of RAPT is -$2.10 B
What is the all time high TTM SGA for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM SGA is -$118.95 M
What is RAPT Therapeutics TTM SGA year-on-year change?
Over the past year, RAPT TTM SGA has changed by -$2.13 B (-8658.61%)